Please use this identifier to cite or link to this item: https://doi.org/10.1167/iovs.18-25221
Title: Prevention and management of myopia and myopic pathology
Authors: Saw, S.-M. 
Matsumura, S.
Hoang, Q.V.
Keywords: Myopia
Pathologic myopia
Prevention
Issue Date: 2019
Publisher: Association for Research in Vision and Ophthalmology Inc.
Citation: Saw, S.-M., Matsumura, S., Hoang, Q.V. (2019). Prevention and management of myopia and myopic pathology. Investigative Ophthalmology and Visual Science 60 (2) : 488-499. ScholarBank@NUS Repository. https://doi.org/10.1167/iovs.18-25221
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Abstract: Myopia is fast becoming a global public health burden with its increasing prevalence, particularly in developed countries. Globally, the prevalence of myopia and high myopia (HM) is 28.3% and 4.0%, respectively, and these numbers are estimated to increase to 49.8% for myopia and 9.8% for HM by 2050 (myopia defined as -0.50 diopter [D] or less, and HM defined as -5.00 D or less). The burden of myopia is tremendous, as adults with HM are more likely to develop pathologic myopia (PM) changes that can lead to blindness. Accordingly, preventive measures are necessary for each step of myopia progression toward vision loss. Approaches to prevent myopia-related blindness should therefore attempt to prevent or delay the onset of myopia among children by increased outdoor time; retard progression from low/ mild myopia to HM, through optical (e.g., defocus incorporated soft contact lens, orthokeratology, and progressive-additional lenses) and pharmacological (e.g., low dose of atropine) interventions; and/or retard progression from HM to PM through medical/surgical treatments (e.g., anti-VEGF therapies, macula buckling, and scleral crosslinking). Recent clinical trials aiming for retarding myopia progression have shown encouraging results. In this article, we highlight recent findings on preventive and early interventional measures to retard myopia, and current and novel treatments for PM. © 2019 The Authors.
Source Title: Investigative Ophthalmology and Visual Science
URI: https://scholarbank.nus.edu.sg/handle/10635/213713
ISSN: 0146-0404
DOI: 10.1167/iovs.18-25221
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1167_iovs_18-25221.pdf794.41 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

59
checked on Jan 26, 2023

Page view(s)

79
checked on Jan 26, 2023

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons